📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Glycolysis: An early marker for vancomycin-specific T-cell activation. (2024)

First Author: Gardner J

Attributed to: A personalised approach to manage adverse reactions to CFTR modulator therapy in patients with cystic fibrosis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/cea.14423

PubMed Identifier: 38177093

Publication URI: http://europepmc.org/abstract/MED/38177093

Type: Journal Article/Review

Volume: 54

Parent Publication: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Issue: 1

ISSN: 0954-7894